Paid Clinical Trials Mississippi
Discover 316 paid clinical trials in Mississippi. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Casdozokitug & Toripalimab, BevacizumabA Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma
Sponsor:
Coherus Biosciences, Inc.
Location:
Code:
NCT06679985
Conditions
Hepatocellular Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Casdozokitug
Toripalimab
Bevacizumab
AcyclovirPhase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System
Sponsor:
National Center for Research Resources (NCRR)
Location:
Code:
NCT00006132
Conditions
Herpes Simplex
Eligibility Criteria
Sex: All
Age: 0 - 28
Healthy Volunteers: Not accepted
Interventions
acyclovir
REACTProact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Sponsor:
Prokidney
Location:
Code:
NCT05099770
Conditions
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Eligibility Criteria
Sex: All
Age: 30 - 70+
Healthy Volunteers: Not accepted
Interventions
Renal Autologous Cell Therapy (REACT)
Sham Comparator
Fianlimab & CemiplimabA Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer
Sponsor:
Regeneron Pharmaceuticals
Location:
Code:
NCT05800015
Conditions
Non-small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
fianlimab
cemiplimab
Pemetrexed
Paclitaxel
Carboplatin
Observational StudyADVENT Post Approval Study
Sponsor:
Boston Scientific Corporation
Location:
Code:
NCT06431815
Conditions
Paroxysmal Atrial Fibrillation
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
FARAPULSE™ Pulsed Field Ablation System
Interested in new trials?
Get alerts for new trials in your area by subscribing now
RemibrutinibA Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT06799000
Conditions
Hidradenitis Suppurativa
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Remibrutinib Dose A
Remibrutinib Dose B
Placebo 1
Placebo 2
SonrotoclaxA Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia
Sponsor:
BeiGene
Location:
Code:
NCT05952037
Conditions
Waldenstrom Macroglobulinemia
Waldenstrom's Macroglobulinemia Recurrent
Waldenstrom's Macroglobulinemia Refractory
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sonrotoclax
Zanubrutinib
AXA1125Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis
Sponsor:
Axcella Health, Inc
Location:
Code:
NCT04880187
Conditions
Non Alcoholic Steatohepatitis (NASH)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
AXA1125
Placebo
AZD2373Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease
Sponsor:
AstraZeneca
Location:
Code:
NCT06824987
Conditions
APOL1-Mediated Kidney Disease
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
AZD2373-Arm 1
AZD2373-Arm 2
Placebo
APOL1 Genotyping Clinical Trial Assay
PCV21Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent Pneumococcal Conjugate Vaccine (PCV21) in Healthy Infants, Toddlers, Children, and Adolescents
Sponsor:
Sanofi Pasteur, a Sanofi Company
Location:
Code:
NCT06838000
Conditions
Pneumococcal Infections
Eligibility Criteria
Sex: All
Age: 7 - 17
Healthy Volunteers: Accepted
Interventions
PCV21
20vPCV